相关实验视频

Updated: Jan 9, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

针对JAK/STAT途径在棕植物 pustulosis:一个审查

Cleopatra Vimbai Chirindo¹, Wang Yun-Jie¹, Hani Tauseef¹

¹Department of Dermatology, Yijishan Hospital, the First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, China.

Annals of medicine

|December 2, 2025

概括

雅努斯酶抑制剂 (JAKi) 在治疗耐火棕植物 pustulosis (PPP) 方面表现有前途. 这些JAK抑制剂为那些对传统疗法没有反应的患者提供了有效的治疗选择,目前正在进行研究以确认长期的安全性和有效性.

科学领域:

皮肤病学皮肤病学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

Palmoplantar pustulosis (PPP) 是一种慢性炎症性皮肤疾病,导致手掌和脚上疼痛的疹.
耐火PPP具有重大治疗挑战,通常对传统治疗无反应.
简氏激酶抑制剂 (JAKi) 正在成为一种潜在的治疗方法,针对PPP的关键炎症途径.

研究的目的:

审查和批判性地分析JAK抑制剂在治疗棕植物 pustulosis当前的临床证据.
检查PPP的JAK抑制剂的机制基础,治疗疗效和安全性概况.
评估JAK抑制剂在治疗耐火PPP病例中的作用.

主要方法:

在主要数据库 (PubMed,Embase,Cochrane Library,Google Scholar) 和USFDA网站上进行文献搜索,截至2025年7月.
包括临床病例报告和早期研究,评估PPP的JAK抑制剂.
对治疗结果,安全性和与JAK抑制剂相关的不良事件数据的分析.

主要成果:

早期的研究和病例报告表明,JAK抑制剂 (例如,托法西提尼布,乌帕达西提尼布) 在耐火PPP中具有良好的结果.
托法西替尼表现出快速和持久的反应,包括在患有 pustulotic 关节骨炎 (PAO) 等并存疾病的患者中.
选择性JAK1抑制剂显示显著改善和良好的耐受性,尽管潜在的不良事件需要监测.

结论:

雅克抑制剂代表了PPP的有希望的治疗策略,特别是在治疗耐药的病例中.
它们调节多种炎症途径的能力比其他向疗法具有优势.
需要进行更大规模的受控试验,以确定最终的疗效,长期安全性和最佳的临床应用.

关键词:

雅克抑制剂的使用在JAK/STAT路径中.棕植物性 pustulosis 的疾病.免疫调节免疫调节免疫调节托法西提尼布 (tofacitinib) 是一种在此之前,upadacitinib 已经在使用中.

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...